{"id":"https://openalex.org/W3209622569","doi":"https://doi.org/10.1136/ijgc-2021-igcs.256","title":"EPV185/#234 Evolving ovarian cancer treatment patterns in the united states from 1982\u20132018: results from the tempus dataset","display_name":"EPV185/#234 Evolving ovarian cancer treatment patterns in the united states from 1982\u20132018: results from the tempus dataset","publication_year":2021,"publication_date":"2021-11-01","ids":{"openalex":"https://openalex.org/W3209622569","doi":"https://doi.org/10.1136/ijgc-2021-igcs.256","mag":"3209622569"},"language":"en","primary_location":{"id":"doi:10.1136/ijgc-2021-igcs.256","doi":"https://doi.org/10.1136/ijgc-2021-igcs.256","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ijgc-2021-igcs.256","pdf_url":"https://ijgc.bmj.com/content/ijgc/31/Suppl_4/A102.2.full.pdf","source":{"id":"https://openalex.org/S41026820","display_name":"International Journal of Gynecological Cancer","issn_l":"1048-891X","issn":["1048-891X","1525-1438"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Gynecological Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ijgc.bmj.com/content/ijgc/31/Suppl_4/A102.2.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057287935","display_name":"Elizabeth A. Szamreta","orcid":"https://orcid.org/0000-0001-7723-3388","observed_orcids":["https://orcid.org/0000-0001-7723-3388"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Szamreta","raw_affiliation_strings":["Merck and Co., Inc., Center for Observational and Real-world Evidence (CORE), Kenilworth, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck and Co., Inc., Center for Observational and Real-world Evidence (CORE), Kenilworth, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003839820","display_name":"Matthew Monberg","orcid":"https://orcid.org/0009-0006-7462-4782","observed_orcids":["https://orcid.org/0009-0006-7462-4782"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Monberg","raw_affiliation_strings":["Merck and Co., Inc., Center for Observational and Real-world Evidence (CORE), Kenilworth, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck and Co., Inc., Center for Observational and Real-world Evidence (CORE), Kenilworth, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013867646","display_name":"Y Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Y. Li","raw_affiliation_strings":["Merck and Co., Inc., Center for Observational and Real-world Evidence (CORE), Kenilworth, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck and Co., Inc., Center for Observational and Real-world Evidence (CORE), Kenilworth, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028772063","display_name":"Megan K. D. Othus","orcid":"https://orcid.org/0000-0001-8176-6371","observed_orcids":["https://orcid.org/0000-0001-8176-6371"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Othus","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Biostatistics and Biomathematics, Seattle, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Biostatistics and Biomathematics, Seattle, USA","institution_ids":["https://openalex.org/I4210089486"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.23193748,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":null,"first_page":"A102","last_page":"A102"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.9789999723434448},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.8320000171661377},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.7020000219345093},{"id":"https://openalex.org/keywords/surgical-treatment","display_name":"surgical treatment","score":0.4779999852180481},{"id":"https://openalex.org/keywords/time-to-surgery","display_name":"time to surgery","score":0.7099999785423279},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.6259999871253967},{"id":"https://openalex.org/keywords/second-line-chemotherapy","display_name":"second-line chemotherapy","score":0.9810000061988831},{"id":"https://openalex.org/keywords/treatment-trends","display_name":"treatment trends","score":0.6129999756813049},{"id":"https://openalex.org/keywords/united-states","display_name":"United States","score":0.42500001192092896}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7831199169158936},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.6582164764404297},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5618119239807129},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5575672388076782},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5375188589096069},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.525434672832489},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5066152811050415},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.4881919026374817},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.48772844672203064},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4529199004173279},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.4225021004676819},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41120070219039917},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3722691535949707},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.11020180583000183},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.09064456820487976},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/ijgc-2021-igcs.256","doi":"https://doi.org/10.1136/ijgc-2021-igcs.256","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ijgc-2021-igcs.256","pdf_url":"https://ijgc.bmj.com/content/ijgc/31/Suppl_4/A102.2.full.pdf","source":{"id":"https://openalex.org/S41026820","display_name":"International Journal of Gynecological Cancer","issn_l":"1048-891X","issn":["1048-891X","1525-1438"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Gynecological Cancer","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1136/ijgc-2021-igcs.256","doi":"https://doi.org/10.1136/ijgc-2021-igcs.256","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ijgc-2021-igcs.256","pdf_url":"https://ijgc.bmj.com/content/ijgc/31/Suppl_4/A102.2.full.pdf","source":{"id":"https://openalex.org/S41026820","display_name":"International Journal of Gynecological Cancer","issn_l":"1048-891X","issn":["1048-891X","1525-1438"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Gynecological Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3209622569.pdf","grobid_xml":"https://content.openalex.org/works/W3209622569.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4297776369","https://openalex.org/W3186780355","https://openalex.org/W3113280500","https://openalex.org/W4412391108","https://openalex.org/W4379282157","https://openalex.org/W3171310621","https://openalex.org/W4399553271","https://openalex.org/W3031697492","https://openalex.org/W4312139509","https://openalex.org/W2890627808"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2021-11-08T00:00:00"}